Harnessing the Power of CAR-NK Cells for Solid Tumors: Challenges, Innovations, and Future Frontiers in Immunotherapy. [PDF]
An M, Yan J, Liu B, Liu Q.
europepmc +1 more source
Forma parte de una serie de textos dedicados al transporte (marítimo,aéreo y terretre). Resulta interesante para los jóvenes entusiasmados con el transporte moderno y la velocidad. Se muestran los coches más rápidos del mundo, Formula 1, Porsche Boxster, McLaren F 1, los dragsters; y también, modelos de automóviles deportivos y prototipos de coches del
Parker, Vic, Connell, Tom (il.)
openaire +1 more source
NR2F6-modified CAR T cells drive extrinsic immunogenic cell death and antigen-agnostic immunity in solid tumors. [PDF]
Klepsch V, Wolf D, Baier G.
europepmc +1 more source
Redesigning CAR therapy to tackle immune effector cell-associated hematotoxicity. [PDF]
Kooniyil MS +4 more
europepmc +1 more source
Balancing the efficacy and safety of chimeric antigen receptor T-cell therapy by affinity combination. [PDF]
Warmuth L +24 more
europepmc +1 more source
Rapid CAR screening and circRNA-driven CAR-NK cells for persistent shed-resistant immunotherapy. [PDF]
Chung JY +11 more
europepmc +1 more source
CAR T cells for pediatric CNS tumors: Clinical experience and reverse translational opportunities. [PDF]
Song KW, Kaur AP, Ramakrishna S.
europepmc +1 more source
Management of hematological toxicities after BCMA-directed CAR-T cell therapy. [PDF]
Cook J +28 more
europepmc +1 more source
CD19-negative relapse after CAR-T cell therapy: mechanisms of antigen escape and lineage switch. [PDF]
Huang J, Huang X, Yu D.
europepmc +1 more source

